Schwarz Pharma moves into OTC/vitamin area with Central Pharmaceuticals acquisition.
This article was originally published in The Tan Sheet
SCHWARZ PHARMA ENTERING U.S. OTC/VITAMIN MARKET WITH PURCHASE OF CENTRAL Pharmaceutical, a privately held branded generic and contract manufacturer based in Seymour, Ind. Milwaukee-based Schwarz Pharma Kremers Urban, a wholly-owned subsidiary of Germany's Schwarz Pharma AG, announced on June 7 it had entered into a merger agreement with Central Pharmaceuticals that provides for the purchase of all outstanding Central stock for $177.5 mil.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC